Product Information

TETRABENAZINE 25 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.3398 per EA under NDC 31722082211. Its NADAC has been published 136 times since Jan 17, 2024.

FDA first approved this application on Feb 3, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TETRABENAZINE 25 MG TABLET

Tetrabenazine
$1.3398per EA

Strength

25 mg/1

NDC

31722082211

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TETRABENAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA204574

FDA Approved

2/3/2016

TE Code

AB

On Market Since

8/17/2015

Pharmacological Classes

Vesicular Monoamine Transporter 2 Inhibitor
Vesicular Monoamine Transporter 2 Inhibitors

Price Statistics

The NADAC for TETRABENAZINE 25 MG TABLET has been published 136 times since Jan 17, 2024, and over the history we have for it it has declined 10.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3398 per EA
All-time high$1.6207 (Apr 16, 2025)
All-time low$1.1286 (Aug 21, 2024)
52-week high$1.3500
52-week low$1.2014
Median price$1.3357
Average price$1.3735
Largest weekly change+29.3% (Nov 20, 2024)
Weeks tracked136
Tracking sinceJan 17, 2024

Price History

1W

+0.3%

1M

+0.3%

3M

+4.1%

6M

+11.2%

1Y

+1.2%

3Y

N/A

5Y

N/A

All

-10.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TETRABENAZINE 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TETRABENAZINE 25 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.3398 per EA (NDC 31722082211), effective Aug 19, 2026.

How has the price of TETRABENAZINE 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for TETRABENAZINE 25 MG TABLET has declined 10.6%. It has been tracked across 136 weekly CMS publications since Jan 17, 2024.

What are the highest and lowest recorded NADAC prices for TETRABENAZINE 25 MG TABLET?

Since Jan 17, 2024, the NADAC for TETRABENAZINE 25 MG TABLET has ranged from a low of $1.1286 (Aug 21, 2024) to a high of $1.6207 (Apr 16, 2025), with a median of $1.3357 per EA.

Are there cheaper alternatives to TETRABENAZINE 25 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TETRABENAZINE 25 MG TABLET, is $1.2044 per EA — about 10% below TETRABENAZINE 25 MG TABLET.

Who manufactures TETRABENAZINE 25 MG TABLET?

TETRABENAZINE 25 MG TABLET (NDC 31722082211) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.